Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US-2016340319-A1 · Nov 24, 2016 · US
US10189776B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10189776-B2 |
| Application number | US-201615758446-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 16, 2016 |
| Priority date | Sep 18, 2015 |
| Publication date | Jan 29, 2019 |
| Grant date | Jan 29, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to a method for the stereoselective preparation of compounds of formula (IV).
Opening claim text (preview).
The invention claimed is: 1. A method for the preparation of a compound of formula (IV), wherein R 1a is NC—; R 1b is H, CH 3 S—, Br, CH 3 SO 2 —; A is NC—; B is CH 3 ; or A and B together with the carbon atoms to which they are attached form a ring selected from the group consisting of cyclopentenone, cyclohexenone and furanone; R 2 is F 3 C—; R 4 is characterised in that the method comprises step (C), where step (C) is the stereoselective reaction of a compound of formula (I) with a compound of formula (III) wherein A, B, R 1a , R 1b , R 2 and R 4 have the meanings as defined above; in the presence of an organo-catalyst of formula (X) wherein R 3 is selected from the group consisting of 2. The method according to claim 1 , for the preparation of compounds of formula (IV-A) wherein a compound of formula (I-A) is reacted with a compound of formula (III) in the presence of an organo-catalyst of formula (X); wherein R 1a , R 1b , R 2 and R 4 have the meanings as defined above. 3. The method according to claim 1 , wherein R 3 of organo-catalyst of formula (X) is 4. The method according to claim 1 , wherein step (C) is carried out at a temperature from 0° C. to −70° C. 5. The method according to claim 1 , wherein step (C) is carried out in a solvent selected from the group consisting of ethyl acetate, Me-THF, THF, dichloromethane, isopropyl acetate, n-butyl acetate, toluene and DMF. 6. The method according to claim 1 , wherein step (C) is carried out using from 0.3 mol % to 10 mol % of the organo-catalyst of formula (X). 7. The method according to claim 1 , wherein step (C) is carried out using from 1.0 to 1.5 molar equivalents of the compound of formula (I). 8. The method according to claim 1 , wherein step (C) is carried out using 1.0 molar equivalents of compound of formula (III). 9. A method for the preparation of organo-catalyst of formula (X), wherein R 3 is characterised in that the method comprises a Suzuki-Miyaura coupling of unprotected 3,3′-dibromo-1,1-bi-2-napthol with 3,5-bis-(trifluoromethyl)phenyl boronic acid in the presence of palladium diacetate and a ligand of formula (Y)
condensed with carbocyclic or heterocyclic rings or ring systems · CPC title
Other additions, e.g. Monsanto-type carbonylations, addition to 1,2-C=X or 1,2-C-X triplebonds, additions to 1,4-C=C-C=X or 1,4-C=-C-X triple bonds with X, e.g. O, S, NH/N · CPC title
the ring being unsaturated · CPC title
the ring being unsaturated · CPC title
by reactions not involving the formation of carbamate groups · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.